SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-02-002935
Filing Date
2002-06-10
Accepted
2002-06-10 13:58:02
Documents
4
Period of Report
2002-06-10
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC b43331ane8vk.htm 8-K 8678
3 AMENDED & RESTATED CERTIFICATE OF INCORPORATION b43331anexv3w1.txt EX-3.1 14267
4 AMENDED AND RESTATED BY-LAWS b43331anexv3w2.txt EX-3.2 42290
5 ANTIGENICS INC - COURTESY PDF b43331ane8vkxpdfy.pdf 8-K 35244
  Complete submission text file 0000950135-02-002935.txt   102483
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 02674763
SIC: 2836 Biological Products, (No Diagnostic Substances)